(Q42970955)

12 November 2017

Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations (English)

1 reference

12 November 2017

1 reference

1 reference

2

1 reference

12 November 2017

8

Susan H Fox

1 reference

12 November 2017

7

Jonathan M Brotchie

1 reference

12 November 2017

5

Naomi P Visanji

1 reference

12 November 2017

3

Tayyeba Darr

1 reference

12 November 2017

4

Lili-Naz Hazrati

1 reference

12 November 2017

6

Donna Pires

1 reference

12 November 2017

Philippe Huot

1

1 reference

PubMed ID

20629135

12 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

12 November 2017

1 reference

12 November 2017

25

1 reference

12 November 2017

10

1 reference

12 November 2017

1399-1408

1 reference

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture.

12 November 2017

1 reference

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

21 January 2018

1 reference

Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model

21 January 2018

1 reference

Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study

21 January 2018

1 reference

Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations

21 January 2018

1 reference

Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease

21 January 2018

1 reference

A review of the role of serotonin receptors in psychiatric disorders

21 January 2018

1 reference

Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors

21 January 2018

1 reference

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

High-resolution imaging reveals highly selective nonface clusters in the fusiform face area.

21 January 2018

1 reference

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

21 January 2018

1 reference

The temporal lobe is a target of output from the basal ganglia

21 January 2018

1 reference

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

21 January 2018

1 reference

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

21 January 2018

1 reference

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

21 January 2018

1 reference

Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide

21 January 2018

1 reference

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors

21 January 2018

1 reference

Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.

21 January 2018

1 reference

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

21 January 2018

1 reference

Altered serotonin metabolism in depressed patients with parkinson's disease.

21 January 2018

1 reference

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes

21 January 2018

1 reference

Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition.

21 January 2018

1 reference

Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.

21 January 2018

1 reference

Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor

21 January 2018

1 reference

Aminergic systems in Alzheimer's disease and Parkinson's disease.

21 January 2018

1 reference

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

21 January 2018

1 reference

Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study.

21 January 2018

1 reference

Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes

21 January 2018

1 reference

Direct activation by dopamine of recombinant human 5‐HT1A receptors: Comparison with human 5‐HT2C and 5‐HT3 receptors

21 January 2018

1 reference

Activation, internalization, and recycling of the serotonin 2A receptor by dopamine.

21 January 2018

1 reference

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

21 January 2018

1 reference

Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias

21 January 2018

1 reference

Levodopa-induced dyskinesias

21 January 2018

1 reference

Separate visual pathways for perception and action

21 January 2018

1 reference

Integration of auditory and visual information about objects in superior temporal sulcus.

21 January 2018

1 reference

Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.

21 January 2018

1 reference

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

21 January 2018

1 reference

Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism

21 January 2018

1 reference

Serotonin 5-HT2A receptors in the CA1 field of the hippocampus mediate head movements in the rabbit

21 January 2018

1 reference

Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23083

1 reference

12 November 2017

1 reference

PubMed ID

20629135